Immune checkpoint combinations from mouse to man.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 7, p. 885, doi. 10.1007/s00262-014-1650-8
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2015 AND VI 64 AND IP 7
Results: 13
1
2
Two distinct effector memory cell populations of WT1 (Wilms' tumor gene 1)-specific cytotoxic T lymphocytes in acute myeloid leukemia patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 7, p. 791, doi. 10.1007/s00262-015-1683-7
- By:
- Publication type:
- Article
3
Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 7, p. 831, doi. 10.1007/s00262-015-1688-2
- By:
- Publication type:
- Article
4
Adoptive T cell therapy combined with intralesional administrations of TG1042 (adenovirus expressing interferon-γ) in metastatic melanoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 7, p. 805, doi. 10.1007/s00262-015-1691-7
- By:
- Publication type:
- Article
5
Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 7, p. 817, doi. 10.1007/s00262-015-1692-6
- By:
- Publication type:
- Article
6
Persistent HPV16/18 infection in Indian women with the A-allele (rs6457617) of HLA-DQB1 and T-allele (rs16944) of IL-1β −511 is associated with development of cervical carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 7, p. 843, doi. 10.1007/s00262-015-1693-5
- By:
- Publication type:
- Article
7
Development of a potent melanoma vaccine capable of stimulating CD8 T-cells independently of dendritic cells in a mouse model.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 7, p. 861, doi. 10.1007/s00262-015-1695-3
- By:
- Publication type:
- Article
8
Cytotoxic T lymphocyte antigen 4 expression in human breast cancer: implications for prognosis.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 7, p. 853, doi. 10.1007/s00262-015-1696-2
- By:
- Publication type:
- Article
9
Immunostimulatory early phenotype of tumor-associated macrophages does not predict tumor growth outcome in an HLA-DR mouse model of prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 7, p. 873, doi. 10.1007/s00262-015-1697-1
- By:
- Publication type:
- Article
10
Orchestrating an immune response against cancer with engineered immune cells expressing αβTCRs, CARs, and innate immune receptors: an immunological and regulatory challenge.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 7, p. 893, doi. 10.1007/s00262-015-1710-8
- By:
- Publication type:
- Article
11
Adoptive immunotherapy of cancer utilizing genetically engineered lymphocytes.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 7, p. 903, doi. 10.1007/s00262-015-1718-0
- By:
- Publication type:
- Article
12
Intratumoral immunotherapy for melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 7, p. 911, doi. 10.1007/s00262-015-1727-z
- By:
- Publication type:
- Article
13
Cancer immunotherapy achieves breakthrough status: 12th annual meeting of the association for cancer immunotherapy (CIMT), Mainz, Germany, May 6-8, 2014.
- Published in:
- 2015
- By:
- Publication type:
- Report